(Q38204538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Effects of iron overload on chronic metabolic diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

José Manuel Fernández-Real

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2

Melania Manco

1 reference

14 March 2020

30 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

The Lancet: Diabetes & Endocrinology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

513-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

Contributions of heme and nonheme iron to human nutrition

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Two to tango: regulation of Mammalian iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hemochromatosis: an endocrine liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Insulin resistance-associated hepatic iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Pancreatic iron and glucose dysregulation in thalassemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron and diabetes risk

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Insulin Resistance and Iron Overload

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Insulin resistance, iron, and the liver

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Ferritins: a family of molecules for iron storage, antioxidation and more.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hepatic iron concentration and total body iron stores in thalassemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hepatic iron and nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hypoferraemia in obese adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

The relationship between obesity and hypoferraemia in adults: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Serum ferritin is associated with visceral fat area and subcutaneous fat area

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Dietary iron overload induces visceral adipose tissue insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 pre-adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Obesity in BSB mice is correlated with expression of genes for iron homeostasis and leptin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Adipocyte iron regulates adiponectin and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Clinical consequences of acquired transfusional iron overload in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Circulating soluble transferrin receptor concentration decreases after exercise-induced improvement of insulin sensitivity in obese individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Human hephaestin expression is not limited to enterocytes of the gastrointestinal tract but is also found in the antrum, the enteric nervous system, and pancreatic {beta}-cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Large amount of (apo)ferritin in the pancreatic insulin cell and its stimulation by glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Serum ferritin as a component of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Cross-talk between iron metabolism and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Insulin Sensitivity and Liver Fat: Role of Iron Load

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hepatic iron stores are increased as assessed by magnetic resonance imaging in a Chinese population with altered glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Relation between iron stores and non-insulin dependent diabetes in men: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

The role of iron in diabetes and its complications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

The role of iron in type 2 diabetes in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Transferrin receptor-1 gene polymorphisms are associated with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Lysosomal iron accumulation in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Dietary iron restriction inhibits progression of diabetic nephropathy in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

A Low-Iron-Available, Polyphenol-Enriched, Carbohydrate-Restricted Diet to Slow Progression of Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Role of brain iron accumulation in cognitive dysfunction: evidence from animal models and human studies.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Cognitive function, dementia and type 2 diabetes mellitus in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Insulin resistance impairs nigrostriatal dopamine function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Neuromuscular manifestations in hereditary haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Effects of an extracellular metal chelator on neurovascular function in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Stored iron and vascular reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron, atherosclerosis, and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron involvement in multiple signaling pathways of atherosclerosis: a revisited hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Back to past leeches: repeated phlebotomies and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron stores, blood donation, and insulin sensitivity and secretion

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Iron and diabetes revisited

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Dietary lean red meat and human evolution

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Mediterranean diet, lower body iron stores and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

Innate immunity, insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970174-8

7 January 2021

10.1016/S2213-8587(13)70174-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731656%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference